A global action agenda for turning the tide on fatty liver disease
Jeffrey V. Lazarus(The Graduate Center, CUNY), Emmanuel Tsochatzis(University College London), Achim Kautz(European Federation of Allergy and Airways Diseases Patients Associations), Terry T.‐K. Huang(The Graduate Center, CUNY), Mary E. Rinella(University of Chicago), Norah A. Terrault(University of Southern California), Paul Brennan(University of Dundee), Patrizia Burra(University of Padua), Alina M. Allen(Mayo Clinic in Arizona), C Wendy Spearman(University of Cape Town), Shiv Kumar Sarin(Institute of Liver and Biliary Sciences), Graciela Castro‐Narro(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Helena Cortez‐Pinto(University of Lisbon), Shira Zelber‐Sagi(Haifa Medical Center), Ramón Bataller(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Aleksander Krag(University of Southern Denmark), Nikos Dedes, Mazen Noureddin(Methodist Hospital), Philip N. Newsome(King's College London), Juan Pablo Arab(Pontificia Universidad Católica de Chile), Luca Valenti(University of Milan), Marcela Villota‐Rivas(Barcelona Institute for Global Health), Marco Arrese(Pontificia Universidad Católica de Chile), Naim Alkhouri(Ohio Aerospace Institute), Hannes Hagström(Karolinska University Hospital), Quentin M. Anstee(Newcastle upon Tyne Hospital), Amalia Gastaldelli(National Research Council), William Alazawi(Queen Mary University of London), Dana Ivancovsky‐Wajcman(Global Health Council), Sven Francque(Inova Health System), Christopher J. Kopka, Zobair M. Younossi(Georgetown University), Henry E. Mark(The Geneva Association), Thomas Berg(Leipzig University of Applied Sciences), Patrizia Carrieri(Inserm), Kenneth Cusi(University of Florida), Diana Romero(The Graduate Center, CUNY), Ajay Duseja(Post Graduate Institute of Medical Education and Research), Jörn M. Schattenberg(Saarland University), Vincent Wai‐Sun Wong(Chinese University of Hong Kong), Saleh A. Alqahtani(Cornell University), Marcelo Silva(The Graduate Center, CUNY)
Cited by 90
Related Papers
Liver fibrosis
|Journal of Clinical Investigation|2005|4.7k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
|Hepatology International|2017|2.2k